Market revenue in 2023 | USD 336.2 million |
Market revenue in 2030 | USD 588.4 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 51.37% in 2023. Horizon Databook has segmented the South Korea interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., and Medtronic PLC are some key players in South Korea. These companies contribute to market growth by providing a wide range of innovative devices and solutions to meet the evolving needs of healthcare providers and patients in the country.
In addition, South Korea has experienced a significant increase in life expectancy due to advancements in healthcare, improved living standards, and public health initiatives. As people live longer, they are more likely to develop age-related cardiovascular conditions, driving the demand for interventional cardiology devices to the market to manage these health issues.
Furthermore, a May 2023 NIH study, predicting the 10-year risk of atherosclerotic cardiovascular disease in South Korea, revealed 4,367 Atherosclerotic CVD (ASCVD) events over a decade. This data underscores the demand for interventional cardiology devices, driving market growth to address cardiovascular health needs effectively in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into South Korea interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account